wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50065301-86E030CA-A1F0-4463-9BCE-54A04E446F71
Q50065301-86E030CA-A1F0-4463-9BCE-54A04E446F71
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50065301-86E030CA-A1F0-4463-9BCE-54A04E446F71
Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab.
P2860
Q50065301-86E030CA-A1F0-4463-9BCE-54A04E446F71
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50065301-86E030CA-A1F0-4463-9BCE-54A04E446F71
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
266559e0b8d9e163cccd4ce4bd16add4846cad77
P2860
A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy.